The National Association of Boards of Pharmacy® (NABP®) today issued a report highlighting a connection between the proliferation of rogue online drug sellers and the prescription drug abuse epidemic.
Saturday, November 1, 2014
IACP's comments Docket ID: FDA-2013-N-1525 Bulk Drug Substances That May Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Request for Nominations
- Thank you for the opportunity to submit our comments on FDA’s request for a list of bulk drug substances that may be used in pharmacy compounding as defined within Section 503A of...
- Public Submission
- Posted:08/11/2014
- ID:FDA-2013-N-1525-0107
Third Question of the Day November 1, 2014 Are there any compounding pharmacies that verify Certificates of Analyses (CoA) data with further testing? If so, is the testing for all parameters and results listed on the CoA's? If no verification is done and there is no warranty, isn't this problematic because of grey markets, counterfeit and substandard bulks that threaten the supply chain?
Bulk Compounds: Docket ID: FDA-2013-N-1525: There were over 200 comments--Check out PCCA's list and note the appended Certificates of Analyses (CoA's) have disclaimer of warranty; express or implied. Also note the disclaimer states that PCCA may be relying on a supplier's (broker/agent) data with further testing.
To Whom It May Concern: Please find attached PCCA's cover letter
and spreadsheet of nominated items to the list of "Bulk Drug Substances
Subscribe to:
Posts (Atom)